{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T03:16:36Z","timestamp":1787454996566,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Futur J Pharm Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The drug discovery and development process is a complex, resource-intensive, and high-risk endeavour, traditionally characterized by long timelines, high costs, and low success rates. Recent advancements in artificial intelligence (AI) have transformed this landscape by enabling data-driven, predictive, and efficient strategies across the entire drug development pipeline. AI technologies, including machine learning (ML), deep learning (DL), and neural networks, have been employed for target identification, lead discovery, structure-based drug design, ADME\/T prediction, toxicity assessment, and de novo molecule generation. AI-driven tools and platforms, such as DeepChem, AlphaFold, and IBM Watson, facilitate virtual screening, chemical space exploration, and patient-specific clinical trial optimization. Additionally, AI has revolutionized advanced applications in drug delivery, including nanorobotics and synergistic combination therapies, and has enhanced nanomedicine formulations for improved efficacy and safety. Despite its transformative potential, AI adoption faces challenges, including data scarcity, high costs, skill gaps, regulatory constraints, and the black box phenomenon. Nevertheless, with appropriate strategies, AI promises to accelerate drug discovery, reduce costs, improve success rates, and enable the development of safer and more effective therapeutics, marking a paradigm shift in pharmaceutical research and development.<\/jats:p>","DOI":"10.1186\/s43094-026-00997-6","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:50:35Z","timestamp":1782474635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artificial intelligence and machine learning in drug discovery and development: a comprehensive review"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1575-4365","authenticated-orcid":false,"given":"Krushna A.","family":"Chaudhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedar S.","family":"Mathpati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish R.","family":"Alte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"3","key":"997_CR1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","volume":"25","author":"R Gupta","year":"2021","unstructured":"Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P (2021) Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers 25(3):1315\u20131360. https:\/\/doi.org\/10.1007\/s11030-021-10217-3","journal-title":"Mol Divers"},{"issue":"3","key":"997_CR2","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3390\/ijms24032026","volume":"24","author":"C Sarkar","year":"2023","unstructured":"Sarkar C, Das B, Rawat VS, Wahlang JB, Nongpiur A, Tiewsoh I et al (2023) Artificial intelligence and machine learning technology driven modern drug discovery and development. Int J Mol Sci 24(3):2026. https:\/\/doi.org\/10.3390\/ijms24032026","journal-title":"Int J Mol Sci"},{"key":"997_CR3","volume-title":"Artificial intelligence and machine learning in drug design and development","year":"2024","unstructured":"Khanna A, El Barachi M, Jain S (eds) (2024) Artificial intelligence and machine learning in drug design and development. Wiley, Hoboken"},{"key":"997_CR4","unstructured":"Titov K (2024) Introduction to artificial intelligence: understanding the basics: Konstantin Titov"},{"issue":"14","key":"997_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2174\/138161207780765954","volume":"13","author":"W Duch","year":"2007","unstructured":"Duch W, Swaminathan K, Meller J (2007) Artificial intelligence approaches for rational drug design and discovery. Curr Pharm Des 13(14):1497\u20131508. https:\/\/doi.org\/10.2174\/138161207780765954","journal-title":"Curr Pharm Des"},{"key":"997_CR6","volume-title":"Fundamentals of artificial intelligence & machine learning","author":"S Ahamed","year":"2023","unstructured":"Ahamed S, Raghavendra SP (2023) Fundamentals of artificial intelligence & machine learning. Academic Guru Publishing House, Bhopal"},{"issue":"18","key":"997_CR7","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","volume":"119","author":"X Yang","year":"2019","unstructured":"Yang X, Wang Y, Byrne R, Schneider G, Meier S (2019) Concepts of artificial intelligence for computer-assisted drug discovery. Chem Rev 119(18):10520\u201310594. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00728","journal-title":"Chem Rev"},{"issue":"7","key":"997_CR8","doi-asserted-by":"publisher","first-page":"e17926","DOI":"10.1016\/j.heliyon.2023.e17926","volume":"9","author":"R Qureshi","year":"2023","unstructured":"Qureshi R, Irfan M, Gondal TM, Khan S, Wu J, Hadi MU et al (2023) AI in drug discovery and its clinical relevance. Heliyon 9(7):e17926. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17926","journal-title":"Heliyon"},{"issue":"9","key":"997_CR9","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/ph16091259","volume":"16","author":"R Han","year":"2023","unstructured":"Han R, Yoon H, Kim G, Lee H, Lee Y (2023) Revolutionizing medicinal chemistry: the application of artificial intelligence (AI) in early drug discovery. Pharmaceuticals 16(9):1259. https:\/\/doi.org\/10.3390\/ph16091259","journal-title":"Pharmaceuticals"},{"issue":"2","key":"997_CR10","doi-asserted-by":"publisher","first-page":"1000e173","DOI":"10.4172\/2329-6887.1000e173","volume":"6","author":"P Agrawal","year":"2018","unstructured":"Agrawal P (2018) Artificial intelligence in drug discovery and development. J Pharmacovigil 6(2):1000e173. https:\/\/doi.org\/10.4172\/2329-6887.1000e173","journal-title":"J Pharmacovigil"},{"issue":"Suppl 4","key":"997_CR11","doi-asserted-by":"publisher","first-page":"S715","DOI":"10.33549\/physiolres.934780","volume":"70","author":"H Farghali","year":"2021","unstructured":"Farghali H, Canov\u00e1 NK, Arora M (2021) The potential applications of artificial intelligence in drug discovery and development. Physiol Res 70(Suppl 4):S715\u2013S722. https:\/\/doi.org\/10.33549\/physiolres.934780","journal-title":"Physiol Res"},{"issue":"6","key":"997_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/ph16060891","volume":"16","author":"A Blanco-Gonz\u00e1lez","year":"2023","unstructured":"Blanco-Gonz\u00e1lez A, Cabez\u00f3n A, Seco-Gonz\u00e1lez A, Conde-Torres D (2023) The role of AI in drug discovery: challenges, opportunities, and strategies. Pharmaceuticals 16(6):891. https:\/\/doi.org\/10.3390\/ph16060891","journal-title":"Pharmaceuticals"},{"issue":"3","key":"997_CR13","doi-asserted-by":"publisher","first-page":"nwad303","DOI":"10.1093\/nsr\/nwad303","volume":"11","author":"F Bai","year":"2024","unstructured":"Bai F, Li S, Li H (2024) AI enhances drug discovery and development. Natl Sci Rev 11(3):nwad303. https:\/\/doi.org\/10.1093\/nsr\/nwad303","journal-title":"Natl Sci Rev"},{"key":"997_CR14","doi-asserted-by":"publisher","unstructured":"Mak KK, Wong YH, Pichika MR (2024) Artificial intelligence in drug discovery and development. In: Hock FJ, Pugsley MK (eds) Drug discovery and evaluation: safety and pharmacokinetic assays. Cham: Springer, p 1461\u201398. https:\/\/doi.org\/10.1007\/978-3-031-35529-5_92","DOI":"10.1007\/978-3-031-35529-5_92"},{"key":"997_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4018\/979-8-3693-1186-8.ch012","volume-title":"Future of AI in biomedicine and biotechnology","author":"N Afrose","year":"2024","unstructured":"Afrose N, Chakraborty R, Hazra A (2024) AI-driven drug discovery and development. Future of AI in biomedicine and biotechnology. IGI Global, Hershey, pp 259\u2013277. https:\/\/doi.org\/10.4018\/979-8-3693-1186-8.ch012"},{"issue":"10","key":"997_CR16","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1021\/acs.molpharmaceut.8b00930","volume":"15","author":"A Zhavoronkov","year":"2018","unstructured":"Zhavoronkov A (2018) Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry. Mol Pharm 15(10):4311\u20134313. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00930","journal-title":"Mol Pharm"},{"issue":"3","key":"997_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.imed.2021.10.001","volume":"2","author":"V Patel","year":"2022","unstructured":"Patel V, Shah M (2022) Artificial intelligence and machine learning in drug discovery and development. Intell Med 2(3):134\u2013140. https:\/\/doi.org\/10.1016\/j.imed.2021.10.001","journal-title":"Intell Med"}],"container-title":["Future Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43094-026-00997-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43094-026-00997-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43094-026-00997-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:50:42Z","timestamp":1782474642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43094-026-00997-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1186\/s43094-026-00997-6","relation":{},"ISSN":["2314-7253"],"issn-type":[{"value":"2314-7253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}